#psychedelic #health #healing

Subscribe to “CBS Mornings” on YouTube: https://www.youtube.com/CBSMornings
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow "CBS Mornings" on Instagram: https://bit.ly/3A13OqA
Like "CBS Mornings" on Facebook: https://bit.ly/3tpOx00
Follow "CBS Mornings" on Twitter: https://bit.ly/38QQp8B
Subscribe to our newsletter: http://cbsn.ws/1RqHw7T​
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com

" />
How psychedelics are helping families, veterans heal from anxiety, depression and PTSD
How psychedelics are helping families, veterans heal from anxiety, depression and PTSD
Like0000000or copy the linkIn the three-part series “Psychedelic Renaissance,” CBS News contributor Lisa Ling explores the natural psychedelic therapies that people are experimenting with to cope with anxiety, PTSD and depression. Ling spoke to a [More]
495 views
16 comments
FDA panel rejects attempt to use psychedelic drug for PTSD treatment
FDA panel rejects attempt to use psychedelic drug for PTSD treatment
Like0000000or copy the linkA key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow [More]
376 views
no comments
Lawmakers lobby for 'Magic Mushrooms' PTSD treatment
Lawmakers lobby for 'Magic Mushrooms' PTSD treatment
Like0000000or copy the linkA State House Committee held a hearing on the potential benefits of ‘Magic Mushrooms’, or psilocybin, for U.S. veterans with PTSD. Doctors at Emory University estimate the research would cost the state [More]
306 views
no comments
MDMA-Assisted Therapy for PTSD: Phase 3, Europe, and Beyond | Rick Doblin | ALPS Conference 2022
MDMA-Assisted Therapy for PTSD: Phase 3, Europe, and Beyond | Rick Doblin | ALPS Conference 2022
Like0000000or copy the linkRick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), explores how potential FDA, EMA, and global regulatory approval of MDMA-assisted therapy for PTSD may contribute to [More]
509 views
no comments